MET and glioblastoma: Compared with MET, MET404 was expressed at substantially comparable or even higher levels in some GSCs and GBM cancerous tissues, as detected with an MET N-terminal antibody that recognizes both MET and MET404 protein (Fig. 2j and Supplementary Fig. 4j, k).